Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial
Andrew Davidson(Royal Children's Hospital), Mary Ellen McCann(Center for Pain and the Brain), Gillian Ormond(Murdoch Children's Research Institute), Nicola Disma(Istituto Giannina Gaslini), Tibor Schuster(Technical University of Munich), Oliver Bagshaw(Birmingham Children's Hospital), Michael Takagi(The University of Melbourne), Robyn Stargatt(La Trobe University), Gaia Giribaldi(Istituto Giannina Gaslini), Jacki Marmor, Penelope L Hartmann(Murdoch Children's Research Institute), Ida Salvo(Ospedale dei Bambini Vittore Buzzi), Geoff Frawley(Royal Children's Hospital), Jurgen C. de Graaff(Erasmus MC - Sophia Children’s Hospital), Rod W. Hunt(Royal Children's Hospital), Britta S. von Ungern‐Sternberg(Princess Margaret Hospital for Children), N S Morton(University of Glasgow), Anthony Absalom(University of Bern), Anne M Lynn(University of Washington), Charles B. Berde(Boston Children's Hospital), David M. Polaner(Seattle Children's Hospital), Graham Bell(Royal Hospital for Children), Pollyanna Hardy(University of Oxford), Sarah Arnup(Murdoch Children's Research Institute), Bruno Guido Locatelli(Ospedale Papa Giovanni XXIII), Liam Dorris(Royal Hospital for Children), Davinia E. Withington(Montreal Children's Hospital), David C. Bellinger(Tufts Medical Center), Niall Wilton(Auckland District Health Board), Peter Szmuk(Outcomes Research Consortium), Joss Thomas(University of Minnesota)
Cited by 1,134
Related Papers
Association Between a Single General Anesthesia Exposure Before Age 36 Months and Neurocognitive Outcomes in Later Childhood
|JAMA|2016|943
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
|The Lancet Oncology|2007|808
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|808